| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Samuel R Haiden, Peter V Apicella, Yi Ma, Gerald A Berkowit. Overexpression of Plants (Basel, Switzerland). vol 11. issue 11. 2024-08-29. PMID:35684291. |
overexpression of cannabinoids are synthesized in glandular stalked trichomes on the female flowers of cannabis sativa (cannabis). |
2024-08-29 |
2024-08-31 |
Not clear |
| Jonathan Tran, Simone Vassiliadis, Aaron C Elkins, Noel O O Cogan, Simone J Rochfor. Rapid In Situ Near-Infrared Assessment of Tetrahydrocannabinolic Acid in Cannabis Inflorescences before Harvest Using Machine Learning. Sensors (Basel, Switzerland). vol 24. issue 16. 2024-08-29. PMID:39204779. |
as the global cannabis industry and research into cannabinoids expands, more efficient and cost-effective analysis methods for determining cannabinoid concentrations will be beneficial to increase efficiencies and maximize productivity. |
2024-08-29 |
2024-09-04 |
Not clear |
| Jonathan Tran, Simone Vassiliadis, Aaron C Elkins, Noel O O Cogan, Simone J Rochfor. Rapid In Situ Near-Infrared Assessment of Tetrahydrocannabinolic Acid in Cannabis Inflorescences before Harvest Using Machine Learning. Sensors (Basel, Switzerland). vol 24. issue 16. 2024-08-29. PMID:39204779. |
previous research on cannabinoid prediction models targeted decarboxylated cannabinoids, such as thc, rather than the naturally occurring precursor, tetrahydrocannabinolic acid (thca), and utilize finely ground cannabis inflorescence. |
2024-08-29 |
2024-09-04 |
Not clear |
| Maitane Oscoz-Irurozqui, Maria Guardiola-Ripoll, Carmen Almodóvar-Payá, Amalia Guerrero-Pedraza, Noemí Hostalet, María Isabel Carrion, Salvador Sarró, J J Gomar, Edith Pomarol-Clotet, Mar Fatjó-Vila. Clinical and cognitive outcomes in first-episode psychosis: focus on the interplay between cannabis use and genetic variability in endocannabinoid receptors. Frontiers in psychology. vol 15. 2024-08-28. PMID:39193030. |
clinical and cognitive outcomes in first-episode psychosis: focus on the interplay between cannabis use and genetic variability in endocannabinoid receptors. |
2024-08-28 |
2024-08-30 |
Not clear |
| Maitane Oscoz-Irurozqui, Maria Guardiola-Ripoll, Carmen Almodóvar-Payá, Amalia Guerrero-Pedraza, Noemí Hostalet, María Isabel Carrion, Salvador Sarró, J J Gomar, Edith Pomarol-Clotet, Mar Fatjó-Vila. Clinical and cognitive outcomes in first-episode psychosis: focus on the interplay between cannabis use and genetic variability in endocannabinoid receptors. Frontiers in psychology. vol 15. 2024-08-28. PMID:39193030. |
however, the effect of the endocannabinoid system genetic variability on the relationship between cannabis use and psychosis has been unexplored, even less in first-episode patients. |
2024-08-28 |
2024-08-30 |
Not clear |
| Maitane Oscoz-Irurozqui, Maria Guardiola-Ripoll, Carmen Almodóvar-Payá, Amalia Guerrero-Pedraza, Noemí Hostalet, María Isabel Carrion, Salvador Sarró, J J Gomar, Edith Pomarol-Clotet, Mar Fatjó-Vila. Clinical and cognitive outcomes in first-episode psychosis: focus on the interplay between cannabis use and genetic variability in endocannabinoid receptors. Frontiers in psychology. vol 15. 2024-08-28. PMID:39193030. |
here, through a case-only design, we investigated the effect of cannabis use and the genetic variability of endocannabinoid receptors on clinical and cognitive outcomes in first-episode psychosis (fep) patients. |
2024-08-28 |
2024-08-30 |
Not clear |
| Hansol Kang, Christopher J Schmoyer, Alexandra Weiss, James D Lewi. Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease. Inflammatory bowel diseases. 2024-08-28. PMID:39197096. |
with the increasing legalization of medical and recreational cannabis, patients and providers have growing interest in the role of cannabinoids in treating inflammatory bowel disease. |
2024-08-28 |
2024-08-31 |
Not clear |
| Nicol Kolar, Ezgi Eyluel Bankoglu, Helga Stoppe. Genotoxicity of selected cannabinoids in human lymphoblastoid TK6 cells. Archives of toxicology. 2024-08-22. PMID:39172143. |
natural non-psychoactive cannabinoids such as cannabigerol (cbg), cannabidiol (cbd), cannabichromene (cbc), cannabidivarin (cbdv), and cannabinol (cbn) are increasingly consumed as constituents of dietary products because of the health benefits claims. |
2024-08-22 |
2024-08-24 |
human |
| Mark M Mims, Aniruddha C Parikh, Zainab Sandhu, Noah DeMoss, Rachad Mhawej, Lurdes Queimad. Surgery-Related Considerations in Treating People Who Use Cannabis: A Review. JAMA otolaryngology-- head & neck surgery. 2024-08-22. PMID:39172477. |
these cannabinoid substances have various systemic effects, and it is critical for otolaryngologists to recognize how cannabis use may contribute to a patient's care. |
2024-08-22 |
2024-08-24 |
Not clear |
| William L Hasler, Omayma Alshaarawy, Thangam Venkatesa. Cannabis use patterns and association with hyperemesis: A comprehensive review. Neurogastroenterology and motility. 2024-08-21. PMID:39164887. |
cannabis has documented antiemetic properties and cannabinoid pharmaceuticals are used in disorders like chemotherapy-induced nausea and vomiting. |
2024-08-21 |
2024-08-23 |
Not clear |
| Elizabeth S Thompson, Jane Alcorn, J Patrick Near. Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport. Sports medicine (Auckland, N.Z.). 2024-08-21. PMID:39168949. |
cannabinoid therapy in athletics: a review of current cannabis research to evaluate potential real-world cannabinoid applications in sport. |
2024-08-21 |
2024-08-24 |
Not clear |
| Elizabeth S Thompson, Jane Alcorn, J Patrick Near. Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport. Sports medicine (Auckland, N.Z.). 2024-08-21. PMID:39168949. |
the changing legal landscape, especially the removal of cannabis from drug testing programs in leagues such as the national basketball association (nba), and endorsements by major league baseball (mlb) for cannabinoid products and the national football league (nfl) for cannabis research, reflects a shift in the acceptability of such substances in sports. |
2024-08-21 |
2024-08-24 |
Not clear |
| Elizabeth S Thompson, Jane Alcorn, J Patrick Near. Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport. Sports medicine (Auckland, N.Z.). 2024-08-21. PMID:39168949. |
adding to the confusion is the lack of consistency with cannabinoid regulations from sport to sport, within or out of competition, and with cannabis bioactive compounds. |
2024-08-21 |
2024-08-24 |
Not clear |
| Elizabeth S Thompson, Jane Alcorn, J Patrick Near. Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport. Sports medicine (Auckland, N.Z.). 2024-08-21. PMID:39168949. |
by synthesizing current cannabis research, this review aims to provide a comprehensive understanding of the applications and implications of cannabinoid use in the realm of athletics. |
2024-08-21 |
2024-08-24 |
Not clear |
| Alessandra Di Salvo, Elisabetta Chiaradia, Monica Sforna, Giorgia Della Rocc. Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review. Veterinary research communications. 2024-08-20. PMID:39162768. |
this manuscript summarizes the findings reported by the scientific studies published so far on the molecular mode of action of the main phytocannabinoids, the localization of cannabinoid receptors in organs and tissues, as well as the pharmacokinetics, efficacy and tolerability of cannabis derivatives in dogs, cats, horses and other species of veterinary interest. |
2024-08-20 |
2024-08-22 |
Not clear |
| Magen N Lord, Emily E Nobl. Hypothalamic cannabinoid signaling: Consequences for eating behavior. Pharmacology research & perspectives. vol 12. issue 5. 2024-08-19. PMID:39155548. |
in parallel to the legalization of cannabis for both medicinal and recreational purposes, cannabinoid use has steadily increased over the last decade in the united states. |
2024-08-19 |
2024-08-21 |
Not clear |
| Omar Oraib. From Chronic Cannabis to Cyclic Chaos: A Glimpse Into Cannabinoid Hyperemesis Syndrome. Cureus. vol 16. issue 7. 2024-08-19. PMID:39156386. |
from chronic cannabis to cyclic chaos: a glimpse into cannabinoid hyperemesis syndrome. |
2024-08-19 |
2024-08-21 |
Not clear |
| Omar Oraib. From Chronic Cannabis to Cyclic Chaos: A Glimpse Into Cannabinoid Hyperemesis Syndrome. Cureus. vol 16. issue 7. 2024-08-19. PMID:39156386. |
this case illustrates the diagnostic difficulties of cannabinoid hyperemesis syndrome (chs) in cannabis users with significant gastrointestinal symptoms. |
2024-08-19 |
2024-08-21 |
Not clear |
| Garrison J B Dyck, Zaid H Maayah, Dean T Eurich, Jason R B Dyc. Understanding the Potential Benefits of Cannabidiol for Patients With Schizophrenia: A Narrative Review. Schizophrenia bulletin open. vol 3. issue 1. 2024-08-15. PMID:39144756. |
however, studies have shown that another major cannabinoid found in cannabis, cannabidiol (cbd), may be a potential alternative or adjunctive treatment for psychosis and schizophrenia. |
2024-08-15 |
2024-08-17 |
Not clear |
| Laith Al-Eitan, Hana Abu Kharma. Effect of EMB-FUBINACA on brain endothelial cell angiogenesis: Expression analysis of angiogenic markers. Naunyn-Schmiedeberg's archives of pharmacology. 2024-08-13. PMID:39136736. |
synthetic cannabinoids represent new psychoactive substances that bind to the cannabinoid receptor 1 (cb1r) and cannabinoid receptor 2 (cb2r) and simulate similar effects of tetrahydrocannabinol, the primary component found in cannabis. |
2024-08-13 |
2024-08-16 |
human |